MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0244377
_PVT_LTD.webp)
Libra Drugs (India) Pvt Ltd - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.15 Cr
▼ 10% YoY
Net loss · FY 2025
₹7.96 Lakh
Net margin -3.7%
EBITDA · FY 2025
₹6.95 Lakh
EBITDA margin 3.2%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹20.22 Lakh
Issued & subscribed
Open charges
₹66.48 Lakh
Satisfied ₹11.14 Lakh
Company age
34 yrs
Est. 1992
Directors on board
3
As per MCA filings
About Libra Drugs (India) Pvt Ltd
Data last updated:
Libra Drugs (India) Pvt Ltd is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 August 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN1992PTC068152. Its GSTIN is 27AAACL2970P1Z1 (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹20.22 Lakh. It is led by directors including Amar Parge Rajaram (Managing Director) and Abhay Rajaram Parge (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Cts No 145 146 92 B Mangalwarpeth, Pune, Maharashtra, India – 411011.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.15 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net loss of ₹7.96 Lakh (net margin -3.7%) and EBITDA of ₹6.95 Lakh (EBITDA margin 3.2%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹66.48 Lakh and satisfied charges of ₹11.14 Lakh on record.
Libra Drugs (India) Pvt Ltd is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0244377). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website libradrugs.com.
Company details
CIN U24232PN1992PTC068152
Registration Number 068152
Incorporation Date 12 August 1992
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0244377
CIN history
Libra Drugs (India) has one previous CIN (Corporate Identification Number): U24232MH1992PTC068152. The current CIN is U24232PN1992PTC068152, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232PN1992PTC068152 | Current |
| U24232MH1992PTC068152 | Previous |
Key People
Amar Parge Rajaram Managing Director Abhay Rajaram Parge Whole-Time Director Umesh Rajaram Parge Director Recognitions & Rankings of Libra Drugs (India)
Contact details
Libra Drugs (India) Pvt Ltd's registered office is in Pune, Maharashtra. Its website is libradrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressCts No 145 146 92 B Mangalwarpeth, Pune, Maharashtra, India – 411011
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Libra Drugs (India) Pvt Ltd, buy the company report.
Comprehensive company report
Libra Drugs (India) Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Libra Drugs (India) is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Libra Drugs (India) Pvt Ltd, buy the company report.
Financials of Libra Drugs (India) Pvt Ltd
FY 2025 filings availableLibra Drugs (India) Pvt Ltd reported revenue of ₹2.15 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹2.15 Cr ▼ 10%
Net loss · FY 2025
₹7.96 Lakh margin -3.7%
EBITDA · FY 2025
₹6.95 Lakh margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 1%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 60%
3 years · compounded
▼ 42%
5 years · compounded
▼ 20%
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 10% fall in the latest year. EBITDA fell 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | -3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Libra Drugs (India) Pvt Ltd, buy the company report.
Board of directors of Libra Drugs (India) Pvt Ltd
Libra Drugs (India) has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amar Parge Rajaram Also directs: Zusamen Lifesciences & Research Private Limited | Managing Director | 12 Aug 1992 | 34 Years 2 Months | Current |
| Abhay Rajaram Parge Also directs: Zusamen Lifesciences & Research Private Limited | Whole-Time Director | 23 Jan 2007 | 19 Years 9 Months | Current |
| Umesh Rajaram Parge Also directs: Zusamen Lifesciences & Research Private Limited | Director | 27 May 1994 | 32 Years 5 Months | Current |
Auditor
Libra Drugs (India) Pvt Ltd is audited by R G BHILARE & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R G BHILARE & CO | FY 2021 | 101411W |
Shareholding
The shareholding of Libra Drugs (India) Pvt Ltd is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Libra Drugs (India) Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹66.48 Lakh
Satisfied charges
₹11.14 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Mar 2025 | 101065540 | Bank of India | ₹30 Lakh | Open | |
| 05 Mar 2025 | 101058771 | Others | ₹36.48 Lakh | Open | |
| 26 Mar 2014 | 10495035 | Bank of India | ₹9.6 Lakh | Satisfied | |
| 03 Aug 2001 | 90091629 | Bank of India | ₹1.54 Lakh | Satisfied |
To see the full charge records of Libra Drugs (India) Pvt Ltd, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Libra Drugs (India) Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Libra Drugs (India) Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Libra Drugs (India) has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACL2970P1Z1 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Libra Drugs (India) Pvt Ltd, buy the company report.
Recent activity
Libra Drugs (India) Pvt Ltd has 6 board changes on record since 1992: 3 appointments and 3 cessations. The latest: Amar Parge Rajaram ceased to be Whole-Time Director on 14 Mar 2024.
AGM
Libra Drugs (India) Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Libra Drugs (India) Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with Bank Of India amounted to Rs. 30.00 Lakh with Charge ID 101065540 was registered on 07 Mar 2025.
Charges
A charge registered on 26 Mar 2014 via Charge ID 10495035 with Bank Of India was fully satisfied on 06 Mar 2025.
Charges
A charge registered on 03 Aug 2001 via Charge ID 90091629 with Bank Of India was fully satisfied on 06 Mar 2025.
Charges
A charge with Others amounted to Rs. 36.48 Lakh with Charge ID 101058771 was registered on 05 Mar 2025.
Ceased
Amar Parge Rajaram ceased to be Whole-Time Director.
Ceased
Kamalini Rajaram Parge ceased to be Whole-Time Director.
Ceased
Rajaram Bapusaheb Parge ceased to be Managing Director.
Charges
A charge with Bank Of India amounted to Rs. 9.60 Lakh with Charge ID 10495035 was registered on 26 Mar 2014.
Appointed
Abhay Rajaram Parge was appointed as Whole-Time Director.
Charges
A charge with Bank Of India amounted to Rs. 1.54 Lakh with Charge ID 90091629 was registered on 03 Aug 2001.
3 earlier events are in the company report.
Frequently asked questions
Libra Drugs (India) is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 August 1992 (34+ years old) and is registered under CIN U24232PN1992PTC068152.
Libra Drugs (India) has 3 current directors:
- Amar Parge Rajaram - Managing Director
- Abhay Rajaram Parge - Whole-Time Director
- Umesh Rajaram Parge - Director
The latest financial statements of Libra Drugs (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Libra Drugs (India) is 27AAACL2970P1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Libra Drugs (India) is U24232PN1992PTC068152. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Libra Drugs (India) was incorporated on 12 August 1992, making it 34+ years old. It is registered with the Registrar of Companies, Pune.
Amar Parge Rajaram ceased to be Whole-Time Director on 14 Mar 2024. Kamalini Rajaram Parge ceased to be Whole-Time Director on 25 Jun 2018. Rajaram Bapusaheb Parge ceased to be Managing Director on 12 Sep 2016. Libra Drugs (India) has 6 board changes on record in total.
Yes, Libra Drugs (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0244377).
Libra Drugs (India) can be reached through the website libradrugs.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Libra Drugs (India) is at Cts No 145 146 92 B Mangalwarpeth, Pune, Maharashtra, India – 411011.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages